Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: Which differences are clinically important?

Health and Quality of Life Outcomes

Volumn 10, Issue , 2012, Pages

  Adamchic, Ilya ^a   Tass, Peter A ^a,b   Langguth, Berthold ^c   Hauptmann, Christian ^a   Koller, Michael ^d   Schecklmann, Martin ^c   Zeman, Florian ^d   Landgrebe, Michael ^c,e  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e Sozialstiftung Bamberg ^*  (Germany)

Author keywords

Clinical significance; Minimal clinically important difference; Receiver operating characteristic; Tinnitus; Tinnitus questionnaire

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROMODULATION; OUTPATIENT CARE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS; TINNITUS; TINNITUS QUESTIONNAIRE; TRANSCRANIAL MAGNETIC STIMULATION;

FEMALE; HUMANS; MALE; QUESTIONNAIRES; TINNITUS;

EID: 84863604876     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-10-79     Document Type: Article

References (56)

1. Eggermont JJ. Central tinnitus. Auris Nasus Larynx 2003, 30(Suppl):S7-12.
2. Weisz N, Moratti S, Meinzer M, Dohrmann K, Elbert T. Tinnitus perception and distress is related to abnormal spontaneous brain activity as measured by magnetoencephalography. PLoS Med 2005, 2:e153. 10.1371/journal.pmed.0020153, 1160568, 15971936.
3. Hoare DJ, Kowalkowski VL, Kang S, Hall DA. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope 2011, 121:1555-1564. 10.1002/lary.21825, 21671234.
4. Noble W. Self-assessment of hearing and related functions. Whurr 1998,
5. Jastreboff PJ. Tinnitus retraining therapy. Prog Brain Res 2007, 166:415-423.
6. Noreña A. Changes in spontaneous neural activity immediately after an acoustic trauma: implications for neural correlates of tinnitus. Hear Res 2003, 183:137-153. 10.1016/S0378-5955(03)00225-9, 13679145.
7. van der Loo E, Gais S, Congedo M, Vanneste S, Plazier M, Menovsky T, Van de Heyning P, De Ridder D. Tinnitus intensity dependent gamma oscillations of the contralateral auditory cortex. PLoS One 2009, 4:e7396. 10.1371/journal.pone.0007396, 2754613, 19816597.
8. Schlee W, Hartmann T, Langguth B, Weisz N. Abnormal resting-state cortical coupling in chronic tinnitus. BMC Neurosci 2009, 10:11. 10.1186/1471-2202-10-11, 2649130, 19228390.
9. Landgrebe M, Binder H, Koller M, Eberl Y, Kleinjung T, Eichhammer P, Graf E, Hajak G, Langguth B. Design of a placebo-controlled, randomized study of the efficacy of repetitive transcranial magnetic stimulation for the treatment of chronic tinnitus. BMC Psychiatry 2008, 8:23. 10.1186/1471-244X-8-23, 2358898, 18412944.
10. De Ridder D, De Mulder G, Menovsky T, Sunaert S, Kovacs S. Electrical stimulation of auditory and somatosensory cortices for treatment of tinnitus and pain. Prog Brain Res 2007, 166:377-388.
11. Dohrmann K, Weisz N, Schlee W, Hartmann T, Elbert T. Neurofeedback for treating tinnitus. 2007, 166:473-554.
12. Langguth B, Landgrebe M, Kleinjung T, Sand GP, Hajak G. Tinnitus and depression. World J Biol Psychiatry 2011, 12:489-500. 10.3109/15622975.2011.575178, 21568629.
13. Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A, Del Bo L, De Ridder D, Diges I, Elbert T, et al. Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. In Tinnitus: Pathophysiology and Treatment. Volume 166 2007, 525-536. Elsevier Science Bv, Amsterdam, Langguth B, Hajak G, Kleinjung T, Cacace A, Moller AR, Progress in Brain Research.
14. Hallam RS, Jakes SC, Hinchcliffe R. Cognitive variables in tinnitus annoyance. Br J Clin Psychol 1988, 27(Pt 3):213-222.
15. Goebel G, Hiller W. Tinnitus-Fragebogen: ein Instrument zur Erfassung von Belastung und Schweregrad bei Tinnitus. Hogrefe, Verl. für Psychologie 1998,
16. Kuk FK, Tyler RS, Russell D, Jordan H. The Psychometric Properties of a Tinnitus Handicap Questionnaire. Ear Hear 1990, 11:434-445. 10.1097/00003446-199012000-00005, 2073977.
17. Wilson PH, Henry J, Bowen M, Haralambous G. Tinnitus Reaction Questionnaire - Psychometric Properties of a Measure of Distress Associated with Tinnitus. J Speech Hear Res 1991, 34:197-201.
18. Flor H, Hoffmann D, Struve M, Diesch E. Auditory discrimination training for the treatment of tinnitus. Appl Psychophysiol Biofeedback 2004, 29:113-120.
19. Bessman P, Heider T, Watten VP, Watten RG. The tinnitus intensive therapy habituation program: a 2-year follow-up pilot study on subjective tinnitus. Rehabil Psychol 2009, 54:133-137.
20. Frank E, Schecklmann M, Landgrebe M, Burger J, Kreuzer P, Poeppl TB, Kleinjung T, Hajak G, Langguth B. Treatment of chronic tinnitus with repeated sessions of prefrontal transcranial direct current stimulation: outcomes from an open-label pilot study. J Neurol 2011, 259:327-333.
21. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health and Quality of Life Outcomes 2006, 4:54. 10.1186/1477-7525-4-54, 1560110, 16925807.
22. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991, 59:12-19.
23. Jacobson NS, Roberts LJ, Berns SB, McGlinchey JB. Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives. J Consult Clin Psychol 1999, 67:300-307.
24. Altman DG. Practical Statistics For Medical Research. Chapman and Hal 1991,
25. King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research 2011, 11:171-184. 10.1586/erp.11.9, 22458505.
26. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989, 10:407-415.
27. Cohen J. Statistical power analysis for the behavioral sciences. L. Erlbaum Associates 1988,
28. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999, 37:469-478. 10.1097/00005650-199905000-00006, 10335749.
29. Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002, 14:109-114. 10.1097/00002281-200203000-00006, 11845014.
30. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003, 56:395-407. 10.1016/S0895-4356(03)00044-1, 12812812.
31. Zeman F, Koller M, Figueiredo R, Aazevedo A, Rates M, Coelho C, Kleinjung T, de Ridder D, Langguth B, Landgrebe M. Tinnitus handicap inventory for evaluating treatment effects: which changes are clinically relevant?. Otolaryngol Head Neck Surg 2011, 145:282-287. 10.1177/0194599811403882, 21493265.
32. Suckfull M, Althaus M, Ellers-Lenz B, Gebauer A, Gortelmeyer R, Jastreboff PJ, Moebius HJ, Rosenberg T, Russ H, Wirth Y, Krueger H. A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. BMC Ear Nose Throat Disord 2011, 11:1. 10.1186/1472-6815-11-1, 3031239, 21223542.
33. Coelho C, Figueiredo R, Frank E, Burger J, Schecklmann M, Landgrebe M, Langguth B, Elgoyhen AB. Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study. Audiol Neurootol 2012, 17:179-188. 10.1159/000335657, 22302057.
34. Wheaton L, Pope J. The Minimally Important Difference for Patient-reported Outcomes in Spondyloarthropathies including Pain, Fatigue, Sleep, and Health Assessment Questionnaire. J Rheumatol 2010, 37:816-822. 10.3899/jrheum.090086, 20110516.
35. Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007, 4:28-37.
36. Yost KJ, Eton DT. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Eval Health Prof 2005, 28:172-191. 10.1177/0163278705275340, 15851772.
37. Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE. Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002, 24:547-561. 10.1016/S0885-3924(02)00529-8, 12551804.
38. Kelly A-M. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emergency Medicine Journal 2001, 18:205-207. 10.1136/emj.18.3.205, 1725574, 11354213.
39. Hagg O, Fritzell P, Nordwall A. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003, 12:12-20.
40. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94:149-158. 10.1016/S0304-3959(01)00349-9, 11690728.
41. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Qual Life Res 2002, 11:207-221. 10.1023/A:1015276414526, 12074259.
42. Landgrebe M, Zeman F, Koller M, Eberl Y, Mohr M, Reiter J, Staudinger S, Hajak G, Langguth B. The Tinnitus Research Initiative (TRI) database: a new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome. BMC Med Inform Decis Mak 2010, 10:42. 10.1186/1472-6947-10-42, 2920857, 20682024.
43. Tass PA, Adamchic I, Freund HJ, von Stackelberg T, Hauptmann C. Counteracting tinnitus by acoustic coordinated reset neuromodulation. Restorative Neurology and Neuroscience 2012, 30:137-159.
44. Adamchic I, Langguth B, Hauptmann C, Tass PA. Psychometric evaluation of Visual Analog Scale for the assessment of chronic tinnitus. Am J Audiol 2012, in press.
45. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008, 61:102-109. 10.1016/j.jclinepi.2007.03.012, 18177782.
46. Fawcett T. An introduction to ROC analysis. Pattern Recognition Letters 2006, 27:861-874.
47. Hauser RA, Auinger P. Determination of minimal clinically important change in early and advanced Parkinson's disease. Mov Disord 2011, 26:813-818. 10.1002/mds.23638, 21437987.
48. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to change of the Roland-Morris back pain questionnaire: Part 1. Phys Ther 1998, 78:1186-1196.
49. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41:582-592.
50. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: The lesson of Cronbach. J Clin Epidemiol 1997, 50:869-879. 10.1016/S0895-4356(97)00097-8, 9291871.
51. Redelmeier DA, Lorig K. Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. Arch Intern Med 1993, 153:1337-1342. 10.1001/archinte.1993.00410110045008, 8507124.
52. Wells GA, Tugwell P, Kraag GR, Baker PRA, Groh J, Redelmeier DA. Minimum Important Difference between Patients with Rheumatoid-Arthritis - the Patients Perspective. J Rheumatol 1993, 20:557-560.
53. Kleinjung T, Steffens T, Sand P, Murthum T, Hajak G, Strutz J, Langguth B, Eichhammer P. Which tinnitus patients benefit from transcranial magnetic stimulation?. Otolaryngol Head Neck Surg 2007, 137:589-595. 10.1016/j.otohns.2006.12.007, 17903575.
54. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate?. Qual Life Res 1995, 4:293-307. 10.1007/BF01593882, 7550178.
55. Goebel G, Kahl M, Arnold W, Fichter M. 15-year prospective follow-up study of behavioral therapy in a large sample of inpatients with chronic tinnitus. Acta Otolaryngol Suppl 2006, 556:70-79.
56. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain 2000, 88:287-294. 10.1016/S0304-3959(00)00339-0, 11068116.